Read more about current CAH research!

Kim Lab Publications:

• Assessment of Facial Morphologic Features in Patients with Congenital Adrenal Hyperplasia using Deep Learning
• Congenital Adrenal Hyperplasia in the Adolescent
• Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
• Decreased Adrenomedullary Function in Infants With Classical Congenital Adrenal Hyperplasia
• Low Adrenomedullary Function in Infancy Predicts Acute Illness in CAH
• Absence of Testicular Adrenal Rest Tumors in Newborns, Infants, and Toddlers with CAH
• Intima-Media Thickness Is Associated with Androgens in Adolescents/Young Adults with CAH
• Improved Medic-Alert Utilization in CAH
• Management of Congenital Adrenal Hyperplasia in Childhood
• Testicular Adrenal Rest Tumors in Boys and Young Adults
• Gray Matter Brain Differences in Youth with CAH
• White Matter Brain Differences in Youth with CAH
• No difference in 2D:4D between Youth with Prenatal Androgen Exposure due to Congenital Adrenal Hyperplasia and Controls
• Early Adiposity Rebound in Youth with Congenital Adrenal Hyperplasia Predicts Childhood Obesity and Adiposity in Adolescence
• Weight Loss Due to Topiramate in Adolescent with CAH
• Digit ratio (2D:4D) and congenital adrenal hyperplasia (CAH): Systematic literature review and meta-analysis.
• Majority of females with a life-long experience of CAH and parents do not consider females with CAH to be intersex
• Patients’ and Caregivers’ Attitudes toward ‘Disorders of Sex Development’ Nomenclature
• Developmental Changes in Food Perception and Preferences
• Brain Subregion Morphology Associated with Obesity and Dietary Self-Control

Additional CAH Publications of interest:
(CAH care guidelines from the Endocrine Society)

• Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
• A Pharmacokinetic and Pharmacodynamic Study of Delayed and Extended Release Hydrocortisone (Chronocort™) versus Conventional Hydrocortisone (Cortef) in the Treatment of Congenital Adrenal Hyperplasia
• The Phenotypic Spectrum of Contiguous Deletion of CYP21A2 and Tenascin XB: Quadricuspid Aortic Valve and Other Midline Defects
• Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
• Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.